Champions Oncology
CSBR
CSBR
34 hedge funds and large institutions have $51.4M invested in Champions Oncology in 2025 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 10 increasing their positions, 6 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
1.41% more ownership
Funds ownership: 41.38% → 42.79% (+1.4%)
5% more capital invested
Capital invested by funds: $49M → $51.4M (+$2.35M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
34
Holding in Top 10
1
Calls
$387K
Puts
$18K
Top Buyers
| 1 | +$998K | |
| 2 | +$694K | |
| 3 | +$483K | |
| 4 |
HIM
Hillsdale Investment Management
Toronto,
Ontario, Canada
|
+$227K |
| 5 |
Goldman Sachs
New York
|
+$201K |
Top Sellers
| 1 | -$1.81M | |
| 2 | -$95K | |
| 3 | -$36K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$9.89K |
| 5 |
BlackRock
New York
|
-$3.83K |
